about
Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in UrineCD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.Inflammation-induced protein carbonylation contributes to poor prognosis for cholangiocarcinoma.PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.Proteomic identification of plasma protein tyrosine phosphatase alpha and fibronectin associated with liver fluke, Opisthorchis viverrini, infection.Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in northeast Thailand.Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.Mechanisms of oxysterol-induced carcinogenesis.Oxidative stress and its significant roles in neurodegenerative diseases and cancer.Cohort profile: cholangiocarcinoma screening and care program (CASCAP).Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte.A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.Chronic Opisthorchis viverrini Infection Changes the Liver Microbiome and Promotes Helicobacter Growth.Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion.Monosodium glutamate (MSG) intake is associated with the prevalence of metabolic syndrome in a rural Thai populationAnnexin A1: A new immunohistological marker of cholangiocarcinoma.Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells.Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma.Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinomaCytokine/chemokine secretion and proteomic identification of upregulated annexin A1 from peripheral blood mononuclear cells cocultured with the liver fluke Opisthorchis viverrini.Roles of liver fluke infection as risk factor for cholangiocarcinoma.Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.Genomic and transcriptional alterations of cholangiocarcinoma.Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool.Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process.Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.Differential Protein Expression Marks the Transition From Infection With Opisthorchis viverrini to Cholangiocarcinoma.Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma.Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis.Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis.Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells.Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression.Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters.High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis.Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
P50
Q28550418-866B3B61-9B13-4138-8F1B-F028285963DAQ30378139-8D28785A-7369-42EA-BC61-50D9DC8139D8Q34179180-42CDBB66-8D3E-442E-AAB5-279DCDA05305Q34420486-354C757E-AECC-4B6E-9301-5EDC0224FA41Q34429098-B95BC5F0-C453-4C40-B170-246029172CB7Q34508893-FCD9DAB6-9D63-41F8-AFB8-C2CA144A5343Q34543698-968A998A-57C3-4108-A013-A768D12A1395Q34619353-3D7C5696-3EE5-45A6-9E67-FE51C754D239Q34704784-445F843B-C766-4FBB-B584-D939F72065E9Q35016411-A34B98B9-4FF0-4B04-9BA9-AD8CD6021681Q35693985-2FE4E7DA-A294-4589-8F46-0850AF7B7293Q35870248-97064075-D68A-4A94-9E75-34E8C19F07C3Q35900738-D3B2401E-09F3-4D2E-937C-EC760B1EF4CFQ36080191-2F4CA1EE-316C-42F0-B88B-EDD37AD067FFQ36180473-E6E03742-69F6-4B11-8C67-93DC7C643B90Q36190329-D46C230E-07B2-4066-938A-52F76FBC801AQ36641619-FA9E29F8-2969-489B-B92D-CCD65DB9754AQ36821610-68DD399D-B13D-43A2-8F53-5B56101726E7Q36887069-4A0199A9-D7F5-4D20-9947-3B58EA2573CCQ37302761-AA656FEF-0320-4EF3-A4E4-F3D538252D16Q37700926-84D698A2-D1FD-46C3-A9A9-9F32CAD43EA8Q37713343-251771B9-E1B6-4672-94E3-D35A2FFD7EB3Q38177235-DF0A9DF2-3A46-4713-9C1C-395726065242Q38177241-BCE5F959-4D55-4B87-929D-D558A3F29389Q38188515-77A764D8-5000-462A-923E-35BED2E30BA5Q38697195-A16BD9CB-BAA6-4578-906E-47F7E18CAF99Q38698388-AAD88BCF-7D56-4EFF-BE6F-B7924A255E50Q38710232-C112C9C1-ACC0-4687-A514-AC8EC21DFFDCQ38715112-B5DB1AC3-6DBA-4E88-BFEE-5779C1EE2254Q38735435-6C60631E-D551-4A2F-9157-737DEE2B318DQ38861060-788C6D4B-174A-45E9-8F70-E2B99F4CEE42Q38889640-22EC3ABD-C696-4A7B-BCE8-6E6395AAD0F3Q38899560-41092CAA-9E47-4120-933B-EDF854D77131Q38923596-541D4857-0B3A-4669-AF76-64C4CF63563DQ38945718-B309244D-6F08-4AA5-BE34-9B1F14F911D3Q38969734-5773423C-F514-4B9B-AA64-8B309A001055Q38990922-FD946BD2-1F9F-4CC5-A59D-CD7BBFAC9153Q38991030-EE0732FE-7430-4F83-ADB6-CCE195C70373Q39079721-235A1A6C-9FDF-4420-AD3A-272EE5D7FA4BQ39129195-C1CE6AAE-914B-4A72-ABF7-59A97D6A94BF
P50
name
Puangrat Yongvanit
@en
type
label
Puangrat Yongvanit
@en
prefLabel
Puangrat Yongvanit
@en